ARCTURUS THERAPEUTICS HLDG I's ticker is and the CUSIP is 03969T909. A total of 3 filers reported holding ARCTURUS THERAPEUTICS HLDG I in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,950 | -38.3% | 9,000 | -30.8% | 0.00% | 0.0% |
| Q2 2023 | $372,840 | +205.0% | 13,000 | +154.9% | 0.00% | – |
| Q1 2023 | $122,247 | -88.6% | 5,100 | -91.9% | 0.00% | -100.0% |
| Q4 2022 | $1,071,872 | +36.5% | 63,200 | +19.2% | 0.00% | 0.0% |
| Q3 2022 | $785,000 | +68.1% | 53,000 | +78.5% | 0.00% | +100.0% |
| Q2 2022 | $467,000 | -79.2% | 29,700 | -64.3% | 0.00% | -50.0% |
| Q1 2022 | $2,243,000 | -10.0% | 83,200 | +23.6% | 0.00% | 0.0% |
| Q4 2021 | $2,491,000 | +39.8% | 67,300 | +80.4% | 0.00% | 0.0% |
| Q3 2021 | $1,782,000 | +213.2% | 37,300 | +122.0% | 0.00% | +100.0% |
| Q2 2021 | $569,000 | -61.6% | 16,800 | -53.2% | 0.00% | -50.0% |
| Q1 2021 | $1,483,000 | -78.8% | 35,900 | -77.7% | 0.00% | -83.3% |
| Q4 2020 | $6,997,000 | +264.0% | 161,300 | +260.0% | 0.01% | +100.0% |
| Q3 2020 | $1,922,000 | -44.9% | 44,800 | -40.0% | 0.01% | -62.5% |
| Q2 2020 | $3,491,000 | +465.8% | 74,700 | +64.5% | 0.02% | +220.0% |
| Q1 2020 | $617,000 | +849.2% | 45,400 | +656.7% | 0.01% | – |
| Q4 2019 | $65,000 | +75.7% | 6,000 | +66.7% | 0.00% | – |
| Q3 2019 | $37,000 | +825.0% | 3,600 | +800.0% | 0.00% | – |
| Q2 2019 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 44,800 | $1,922,000 | 0.01% |
| SIMPLEX TRADING, LLC | 523 | $2,243,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |